Nasal microbiota and symptom persistence in acute respiratory tract infections in infants
- PMID: 30519565
- PMCID: PMC6275129
- DOI: 10.1183/23120541.00066-2018
Nasal microbiota and symptom persistence in acute respiratory tract infections in infants
Abstract
Acute respiratory tract infections (ARI) in infancy have been implicated in the development of chronic respiratory disease, but the complex interplay between viruses, bacteria and host is not completely understood. We aimed to prospectively determine whether nasal microbiota changes occur between the onset of the first symptomatic ARI in the first year of life and 3 weeks later, and to explore possible associations with the duration of respiratory symptoms, as well as with host, environmental and viral factors. Nasal microbiota of 167 infants were determined at both time-points by 16S ribosomal RNA-encoding gene PCR amplification and subsequent pyrosequencing. Infants were clustered based on their nasal microbiota using hierarchical clustering methods at both time-points. We identified five dominant infant clusters with distinct microbiota at the onset of ARI but only three clusters after 3 weeks. In these three clusters, symptom persistence was overrepresented in the Streptococcaceae-dominated cluster and underrepresented in the cluster dominated by "Others" (p<0.001). Duration of symptoms was not associated with the type of respiratory virus. Infants with prolonged respiratory symptoms after their first ARI tend to exhibit distinct microbial compositions, indicating close microbiota-host interactions that seem to be of importance for symptom persistence and recovery.
Conflict of interest statement
Conflict of interest: R.P. Neumann reports grants from Vifor AG, Villars-sur-Glâne, Switzerland (unrestricted research grant for laboratory materials for this study), during the conduct of the study. Conflict of interest: M. Hilty has nothing to disclose. Conflict of interest: B. Xu has nothing to disclose. Conflict of interest: J. Usemann has nothing to disclose. Conflict of interest: I. Korten has nothing to disclose. Conflict of interest: M. Mika has nothing to disclose. Conflict of interest: L. Müller has nothing to disclose. Conflict of interest: P. Latzin reports personal fees from Gilead, Novartis, Polyphor, Roche, Santhera, Schwabe, Vertex, Vifor and Zambon. Conflict of interest: U. Frey reports grants from the Swiss National Science Foundation (grant no. 320030_163311), during the conduct of the study.
Figures
References
-
- Kusel MM, de Klerk NH, Holt PG, et al. . Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study. Pediatr Infect Dis J 2006; 25: 680–686. - PubMed
-
- Regamey N, Kaiser L, Roiha HL, et al. . Viral etiology of acute respiratory infections with cough in infancy: a community-based birth cohort study. Pediatr Infect Dis J 2008; 27: 100–105. - PubMed
-
- Bisgaard H, Hermansen MN, Buchvald F, et al. . Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 2007; 357: 1487–1495. - PubMed
LinkOut - more resources
Full Text Sources